Prolactin serum levels and breast cancer: relationships with risk factors and tumour characteristics among pre- and postmenopausal women in a population-based case–control study fr...

por Faupel-Badger, J M, Sherman, M E, Garcia-Closas, M, Gaudet, M M, Falk, R T, Andaya, A, Pfeiffer, R M, Yang, X R, Lissowska, J, Brinton, L A, Peplonska, B, Vonderhaar, B K, Figueroa, J D
Publicado 2010

Education, survival and avoidable deaths in cancer patients in Finland

por Pokhrel, A, Martikainen, P, Pukkala, E, Rautalahti, M, Seppä, K, Hakulinen, T
Publicado 2010

A clinical risk score to predict 3-, 5- and 10-year survival in patients undergoing surgery for Dukes B colorectal cancer

por McMillan, D C, McArdle, C S, Morrison, D S
Publicado 2010

Expression of HER-2 affects patient survival and paclitaxel sensitivity in endometrial cancer

por Mori, N, Kyo, S, Nakamura, M, Hashimoto, M, Maida, Y, Mizumoto, Y, Takakura, M, Ohno, S, Kiyono, T, Inoue, M
Publicado 2010

A phase I/II trial of sorafenib and infliximab in advanced renal cell carcinoma

por Larkin, J M G, Ferguson, T R, Pickering, L M, Edmonds, K, James, M G, Thomas, K, Banerji, U, Berns, B, de Boer, C, Gore, M E
Publicado 2010

Molecular imaging of glioblastoma multiforme using anti-insulin-like growth factor-binding protein-7 single-domain antibodies

por Iqbal, U, Albaghdadi, H, Luo, Y, Arbabi, M, Desvaux, C, Veres, T, Stanimirovic, D, Abulrob, A
Publicado 2010

Socioeconomic position and participation in colorectal cancer screening

por Frederiksen, B L, Jørgensen, T, Brasso, K, Holten, I, Osler, M
Publicado 2010

A phase II study of weekly docetaxel and cisplatin plus oral tegafur/uracil and leucovorin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer

por Li, C-P, Chen, J-S, Chen, L-T, Yen, C-J, Lee, K-D, Su, W-P, Lin, P-C, Lu, C-H, Tsai, H-J, Chao, Y
Publicado 2010

Angiotensin-2 receptors (AT1-R and AT2-R), new prognostic factors for renal clear-cell carcinoma?

por Dolley-Hitze, T, Jouan, F, Martin, B, Mottier, S, Edeline, J, Moranne, O, Le Pogamp, P, Belaud-Rotureau, M-A, Patard, J-J, Rioux-Leclercq, N, Vigneau, C
Publicado 2010

Quantitative promoter methylation differentiates carcinoma ex pleomorphic adenoma from pleomorphic salivary adenoma

por Schache, A G, Hall, G, Woolgar, J A, Nikolaidis, G, Triantafyllou, A, Lowe, D, Risk, J M, Shaw, R J, Liloglou, T
Publicado 2010

Tumours with loss of MSH6 expression are MSI-H when screened with a pentaplex of five mononucleotide repeats

por You, J-F, Buhard, O, Ligtenberg, M J L, Kets, C M, Niessen, R C, Hofstra, R M W, Wagner, A, Dinjens, W N M, Colas, C, Lascols, O, Collura, A, Flejou, J-F, Duval, A, Hamelin, R
Publicado 2010

Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial

por Parker, Catriona, Waters, Rachel, Leighton, Carly, Hancock, Jeremy, Sutton, Rosemary, Moorman, Anthony V, Ancliff, Philip, Morgan, Mary, Masurekar, Ashish, Goulden, Nicholas, Green, Nina, Révész, Tamas, Darbyshire, Philip, Love, Sharon, Saha, Vaskar
Publicado 2010

LY6K is a novel molecular target in bladder cancer on basis of integrate genome-wide profiling

por Matsuda, R, Enokida, H, Chiyomaru, T, Kikkawa, N, Sugimoto, T, Kawakami, K, Tatarano, S, Yoshino, H, Toki, K, Uchida, Y, Kawahara, K, Nishiyama, K, Seki, N, Nakagawa, M
Publicado 2011

PBOX-15, a novel microtubule targeting agent, induces apoptosis, upregulates death receptors, and potentiates TRAIL-mediated apoptosis in multiple myeloma cells

por Maginn, E N, Browne, P V, Hayden, P, Vandenberghe, E, MacDonagh, B, Evans, P, Goodyer, M, Tewari, P, Campiani, G, Butini, S, Williams, D C, Zisterer, D M, Lawler, M P, McElligott, A M
Publicado 2011

The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600)

por Giorgi Rossi, P, Marsili, L M, Camilloni, L, Iossa, A, Lattanzi, A, Sani, C, Di Pierro, C, Grazzini, G, Angeloni, C, Capparucci, P, Pellegrini, A, Schiboni, M L, Sperati, A, Confortini, M, Bellanova, C, D'Addetta, A, Mania, E, Visioli, C B, Sereno, E, Carozzi, F
Publicado 2011

Phase I clinical, pharmacokinetic and pharmacodynamic study of SB939, an oral histone deacetylase (HDAC) inhibitor, in patients with advanced solid tumours

por Razak, A R A, Hotte, S J, Siu, L L, Chen, E X, Hirte, H W, Powers, J, Walsh, W, Stayner, L-A, Laughlin, A, Novotny-Diermayr, V, Zhu, J, Eisenhauer, E A
Publicado 2011

Enhancement of osteoclastogenic activity in osteolytic prostate cancer cells by physical contact with osteoblasts

por Shiirevnyamba, A, Takahashi, T, Shan, H, Ogawa, H, Yano, S, Kanayama, H, Izumi, K, Uehara, H
Publicado 2011

An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study

por Proctor, M J, Morrison, D S, Talwar, D, Balmer, S M, O'Reilly, D S J, Foulis, A K, Horgan, P G, McMillan, D C
Publicado 2011

Patient and tumour characteristics, management, and age-specific survival in women with breast cancer in the East of England

por Ali, A M G, Greenberg, D, Wishart, G C, Pharoah, P
Publicado 2011

Morphological predictors of BRCA1 germline mutations in young women with breast cancer

por Southey, M C, Ramus, S J, Dowty, J G, Smith, L D, Tesoriero, A A, Wong, E E M, Dite, G S, Jenkins, M A, Byrnes, G B, Winship, I, Phillips, K-A, Giles, G G, Hopper, J L
Publicado 2011